Research On The Working Capital Efficiency Of Sinopharm Holding Shanxi Co.,LTD

With the rapid development of economic globalization,the increasing rigid demand for medicines and the rapid progress of medical technology,both market size and sales profit of the pharmaceutical circulation industry are in a steady growth trend.But along with this is the deepening of health care reform and the introduction of policies to reduce the proportion of drugs,as well as the increasingly fierce competition in the pharmaceutical industry.For pharmaceutical enterprises,the current operating environment has undergone tremendous changes,and their own production and operation modes need to be adjusted and improved accordingly.As the second largest state-owned pharmaceutical company in Shaanxi Province,Shaanxi Pharmaceutical Holdings Co.,Ltd.must pay close attention to the problem of operating cash flow and improve the efficiency of capital allocation.The purpose of this paper is to help Sinopharm Holding Shanxi Co.,Ltd.solve the problem of working capital allocation,optimize its working capital allocation,so that the enterprise can be stable and sustainable under the background of deepening medical reform.Through investigation,this paper finds that in the process of the company's continuous operation,the operating cycle is too long,and there are serious problems in the allocation of operating funds.After that,the paper applies the theory of enterprise operation management and financial management to analyze the causes of capital allocation,and finds out the main influencing factors from the perspective of supply chain management.Then,according to the theory of supply chain management and the concept of working capital management,this paper puts forward some specific solutions through lean supply chain management,adjusting the business structure,diversifying the means of capital control,and incorporating capital management into performance appraisal,and explains the implementation and control of the solutions.It is hoped that this will help the enterprise optimize the allocation of funds,improve the efficiency of capital use,reduce the occupation and precipitation of funds,improve its competitiveness in the pharmaceutical circulation industry,and stabilize sustainable development under the policy environment of deepening medical reform.At the same time,I hope to provide references for other similar enterprises in the pharmaceutical industry when they encounter relevant problems in their development.